C/O GT BIOPHARMA, INC. 505 MONTGOMERY, STREET, 9TH AND 10TH FLOORS, SAN FRANCISCO
/s/ Andrew J. Ritter
29 May 2025
0001631671
No securities are beneficially owned.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.